Alkaloids from Coptis Chinensis Root Promote Glucose Uptake in C2C12 Myotubes
Overview
Rehabilitation Medicine
Affiliations
The root of Coptis chinensis Franch. (COCH) is regularly used for medicinal purposes, and has been prescribed alone or in combination with other traditional herbs for the treatment of diabetes. To investigate the effects of COCH on glucose utilization by skeletal muscles, we prepared an ethanol extract of COCH root (COCH-Et) partitioned with dichloromethane, n-butanol, and water and tested its effects on glucose uptake in differentiated C2C12 myotubes. We found that dichloromethane and n-butanol sub-fractions of COCH-Et promoted glucose uptake in differentiated C2C12 cells at 50 μg/mL. Further fractionation of these preparations by using column chromatography, analysis of their effects on glucose uptake and characterization using nuclear magnetic resonance, mass spectrometry, and thin layer chromatography helped identify two new alkaloids, 8,13-dioxocoptisine hydroxide (1) and coptisonine (2), together with eleven known compounds. These were isolated from the dichloromethane layer of COCH-Et. In particular, exposure of C2C12 cells to berberine (6) at 12.5 and 6.25 μg/mL for 24h resulted in significant promotion of glucose uptake. Coptisonine (2) and octadecyl caffeate (9) also stimulated glucose uptake at 25 and 50 μg/mL. These findings indicate that active constituents of COCH root may help alleviate hyperglycemia in diabetes by promoting glucose uptake by skeletal muscles.
Zheng Y, Zhang M, Wu X, Tan R, Jiang H Curr Top Med Chem. 2024; 24(23):2013-2032.
PMID: 39136504 DOI: 10.2174/0115680266305274240723120426.
Li S, Xu D, Chen Y, Fu R, Tang Y Front Pharmacol. 2024; 15:1399460.
PMID: 38983920 PMC: 11231094. DOI: 10.3389/fphar.2024.1399460.
Zhao Z, Ma R, Ma Y, Zhao L, Wang L, Fang Y Molecules. 2024; 29(10).
PMID: 38792165 PMC: 11123979. DOI: 10.3390/molecules29102304.
Antifungal alkaloids from Mahonia fortunei against pathogens of postharvest fruit.
Wang X, Wang Z, Zhao Y, Wang H, Xiang M, Liu Y Nat Prod Bioprospect. 2023; 13(1):10.
PMID: 37012512 PMC: 10070590. DOI: 10.1007/s13659-023-00374-3.
Pan L, Zhai X, Duan Z, Xu K, Liu G Front Pharmacol. 2022; 13:956313.
PMID: 36160405 PMC: 9492976. DOI: 10.3389/fphar.2022.956313.